Pfizer Acquisitions

Pfizer has acquired 45 companies and its latest acquisition was Lucira Health, Inc. on Apr 2023

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Lucira Health, Inc.

Apr 2023

Source »
$36.4M
Lucira Health is a California-based medical device company that develops at-home COVID-19 test kits for the healthcare market.
Seagen, Inc.

Mar 2023

Source »
$43B
Seagen is a Washington-based biotechnology company that develops and commercializes therapies for the treatment of cancer.
Global Blood Therapeutics, Inc.

Aug 2022

Source »
$5.4B
GBT is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases.
Biohaven Pharmaceutical Holding Company Ltd.

May 2022

Source »
$11.6B
Biohaven is a Connecticut-based pharmaceutical company that researches and develops novel drugs for the treatment of neurological and neuropsychiatric diseases.
ReViral Ltd.

Apr 2022

Source »
$525M
Reviral is an England-based biopharmaceutical company that develops and commercializes antiviral therapeutics for the treatment of the respiratory syncytial virus.

Frequently Asked Questions about Pfizer

  1. What companies did Pfizer acquire?

    Companies acquired by Pfizer include Lucira Health, Seagen and GBT
  2. How many acquisitions does Pfizer have?

    Pfizer has acquired 45 companies including Lucira Health, Seagen and GBT.
  1. How many acquisitions did Pfizer make in 2023?

    In 2023 Pfizer acquired 2 companies including Lucira Health and Seagen.